Dove

Product NDC: 64942-1333
11-digit product format: 649421333
Labeler code: 64942
Product ID: 64942-1333_60c50139-6d3a-48b2-a92f-a6832f95251f
Type: HUMAN OTC DRUG
Nonproprietary name: AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE
Dosage form: LOTION
Route: TOPICAL
Labeler: CONOPCO Inc. d/b/a Unilever
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2016-01-12
Marketing end: 0000-00-00
Substance: AVOBENZONE; ENSULIZOLE; OCTISALATE; OCTOCRYLENE
Active strength: 2 g/100mL; g/100mL; g/100mL; g/100mL
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64942-1333		I	Inactivated by FDA	2026-10-05
excluded package	package	64942-1333	64942-1333-2	I	Inactivated by FDA	2026-10-05
excluded package	package	64942-1333	64942-1333-3	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 63 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64942-1333-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64942-1333-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64942-1333-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64942-1333-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64942-1333-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64942-1333-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64942-1333-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64942-1333-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64942-1333-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64942-1333-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64942-1333-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64942-1333-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64942-1333-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64942-1333-3	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64942-1333-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64942-1333-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64942-1333-2	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64942-1333-3	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64942-1333-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64942-1333-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64942-1333-2	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64942-1333-3	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64942-1333-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64942-1333-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64942-1333-2	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64942-1333-3	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64942-1333-2	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64942-1333-3	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64942-1333-2	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64942-1333-3	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64942-1333-3	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64942-1333-2	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64942-1333-3	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64942-1333-2	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64942-1333-3	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64942-1333-2	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64942-1333-3	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64942-1333-2	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64942-1333-3	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64942-1333-2	`e2bbac7714bc…`	`27bdfed8d636…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64942-1333-2	2020-01-31	C162847	48780-1	9d75b9d0-4de9-f424-e053-dadaa90a57ce	Dove Men plus Care Sensitive Face Lotion SPF 15
64942-1333-3	2020-01-31	C162847	48780-1	9d75b9d0-4de9-f424-e053-dadaa90a57ce	Dove Men plus Care Sensitive Face Lotion SPF 15

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64942-1333-1	DoveMen plus Care Sensitive Face	50 mL in 1 BOTTLE, PUMP	LOTION	50	3
64942-1333-2	DoveMen plus Care Sensitive Face	1 in 1 CARTON	LOTION	1	3
64942-1333-3	DoveMen plus Care Sensitive Face	15 mL in 1 TUBE	LOTION	15	3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
ENSULIZOLE	ACTIVE INGREDIENT	9YQ9DI1W42	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
ENSULIZOLE	ACTIVE MOIETY	9YQ9DI1W42	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
GLYCOL STEARATE	INACTIVE INGREDIENT	0324G66D0E	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
POTASSIUM STEARATE	INACTIVE INGREDIENT	17V812XK50	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
STEARAMIDE AMP	INACTIVE INGREDIENT	U3K8640346	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64942-1333	DOVE MEN PLUS CARE SENSITIVE FACE (AVOBENZONE, ENSULIZOLE, OCTICSALATE, OCTOCRYLENE) LOTION [CONOPCO INC. D/B/A UNILEVER]	3	Legacy NDC, 3 package rows	20160112_a5fcc7df-cac4-4f5c-9990-4e9e6c40d6e1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G63QQF2NOX	AVOBENZONE	70356-09-1	AVOBENZONE
9YQ9DI1W42	ENSULIZOLE	27503-81-7	ENSULIZOLE
4X49Y0596W	OCTISALATE	118-60-5	OCTISALATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
64942-1333-1	64942133301	50 mL in 1 BOTTLE, PUMP	50 ml	Historical
64942-1333-2	64942133302	1 in 1 CARTON		Historical
64942-1333-3	64942133303	15 mL in 1 TUBE	15 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Dove Men plus Care Sensitive Face Lotion SPF 15	CONOPCO Inc. d/b/a Unilever \| Unilever Manufacturing (US), Inc.	2015-08-20	HUMAN OTC DRUG LABEL	3